Protein–protein interactions and disease: Use of S. cerevisiae as a model system

Yasugi, 1997, Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins, J. Virol., 71, 891, 10.1128/JVI.71.2.891-899.1997 Walhout, 2000, Protein interaction mapping in C. elegans using proteins involved in vulval development, Science, 287, 116, 10.1126/science.287.5450.116 Rain, 2001, The protein–protein interaction map of Helicobacter pylori, Nature, 409, 211, 10.1038/35051615 Ito, 2001, A comprehensive two-hybrid analysis to explore the yeast protein interactome, Proc. Natl. Acad. Sci. U. S. A., 98, 4569, 10.1073/pnas.061034498 Uetz, 2000, A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae, Nature, 403, 623, 10.1038/35001009 Li, 2004, A map of the interactome network of the metazoan C. elegans, Science, 303, 540, 10.1126/science.1091403 Giot, 2003, A protein interaction map of Drosophila melanogaster, Science, 302, 1727, 10.1126/science.1090289 Stelzl, 2005, A human protein–protein interaction network: a resource for annotating the proteome, Cell, 122, 957, 10.1016/j.cell.2005.08.029 Rual, 2005, Towards a proteome-scale map of the human protein–protein interaction network, Nature, 437, 1173, 10.1038/nature04209 Gavin, 2002, Functional organization of the yeast proteome by systematic analysis of protein complexes, Nature, 415, 141, 10.1038/415141a Ho, 2002, Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry, Nature, 415, 180, 10.1038/415180a Gavin, 2006, Proteome survey reveals modularity of the yeast cell machinery, Nature, 440, 631, 10.1038/nature04532 Krogan, 2006, Global landscape of protein complexes in the yeast Saccharomyces cerevisiae, Nature, 440, 637, 10.1038/nature04670 A.C. Gavin, Protein–protein interactions, in: M.R. Wilkins, R.D. Appel, K.L Williams, D.F. Hochstrasser (Eds.) Proteome Research: strategies, techniques and practice. Springer, Berlin (in press). Reymond, 1995, p16 proteins from melanoma-prone families are deficient in binding to Cdk4, Oncogene, 11, 1173 Sun, 2002, Functional alterations of human exonuclease 1 mutants identified in atypical hereditary nonpolyposis colorectal cancer syndrome, Cancer Res., 62, 6026 Wiszniewski, 2003, Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II, Immunogenetics, 54, 747, 10.1007/s00251-002-0521-1 Anderson, 1998, Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand, Hum. Mol. Genet., 7, 1475, 10.1093/hmg/7.9.1475 Buchanan, 2001, Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function, Mol. Endocrinol., 15, 46, 10.1210/me.15.1.46 Shen, 2003, The N-terminal domain of the large subunit of human replication protein A binds to Werner syndrome protein and stimulates helicase activity, Mech. Ageing Dev., 124, 921, 10.1016/S0047-6374(03)00164-7 Han, 2004, Evidence for dynamically organized modularity in the yeast protein–protein interaction network, Nature, 430, 88, 10.1038/nature02555 Dziembowski, 2004, Recent developments in the analysis of protein complexes, FEBS Lett., 556, 1, 10.1016/S0014-5793(03)01357-7 O'Brien, 2004, OrthoDisease: a database of human disease orthologs, Hum. Mutat., 24, 112, 10.1002/humu.20068 Foury, 1997, Human genetic diseases: a cross-talk between man and yeast, Gene, 195, 1, 10.1016/S0378-1119(97)00140-6 Andrade, 1998, Updated catalogue of homologues to human disease-related proteins in the yeast genome, FEBS Lett., 426, 7, 10.1016/S0014-5793(98)00277-4 Rubin, 2000, Comparative genomics of the eukaryotes, Science, 287, 2204, 10.1126/science.287.5461.2204 Mager, 2005, Yeast as a model for medical and medicinal research, Trends Pharmacol. Sci., 26, 265, 10.1016/j.tips.2005.03.004 Fisher, 2004, Human disease-related mutations in cytochrome b studied in yeast, J. Biol. Chem., 279, 12951, 10.1074/jbc.M313866200 Outerio, 2003, Yeast cells provide insight into alpha-synuclein biology and pathobiology, Science, 302, 1772, 10.1126/science.1090439 Wanders, 2004, Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders, Clin. Genet., 67, 107, 10.1111/j.1399-0004.2004.00329.x Dwight, 2004, Saccharomyces genome database: underlying principles and organisation, Brief. Bioinform., 5, 9, 10.1093/bib/5.1.9 Edgar, 2006, Multiple sequence alignment, Curr. Opin. Struct. Biol., 16, 368, 10.1016/j.sbi.2006.04.004 Do, 2005, ProbCons: probabilistic consistency-based multiple alignment of amino acid sequences, Genome Res., 15, 330, 10.1101/gr.2821705 Henikoff, 1992, Amino acid substitution matrices from protein blocks, Proc. Natl. Acad. Sci. U. S. A., 89, 10915, 10.1073/pnas.89.22.10915 Alper, 2002, Genetic diseases of acid–base transporters, Annu. Rev. Physiol., 64, 899, 10.1146/annurev.physiol.64.092801.141759 Karet, 1999, Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness, Nat. Genet., 21, 84, 10.1038/5022 Smith, 2000, Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing, Nat. Genet., 26, 71, 10.1038/82492 Beyenbach, 2006, The V type H+ ATPase molecular structure and function, physiological roles and regulation, J. Exp. Biol., 209, 577, 10.1242/jeb.02014 Ochotny, 2006, Effects of human a3 and a4 mutations that result in osteopetrosis and distal renal tubular acidosis on yeast V-ATPase expression and activity, J. Biol. Chem., 281, 26102, 10.1074/jbc.M601118200 Bueno, 2006, Energetics of aliphatic deletions in protein cores, Protein Sci., 15, 1858, 10.1110/ps.062274906 Li, 2002, Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2, Mol. Cell, 9, 1045, 10.1016/S1097-2765(02)00527-0 Sun, 2002, Functional alterations of human exonuclease 1 mutants identified in atypical hereditary nonpolyposis colorectal cancer syndrome, Cancer Res., 62, 6026 Robinson, 2005, The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot–Marie–Tooth disease, J. Biol. Chem., 280, 31699, 10.1074/jbc.M505159200 Bourne, 1991, The GTPase superfamily: conserved structure and molecular mechanism, Nature, 349, 117, 10.1038/349117a0 Zimmer, 2000, A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization, J. Biol. Chem., 275, 25672, 10.1074/jbc.M000851200 Naureckiene, 2003, Functional characterization of Narc 1, a novel proteinase related to proteinase K, Arch. Biochem. Biophys., 420, 55, 10.1016/j.abb.2003.09.011 Fransen, 2001, Human pex19p binds peroxisomal integral membrane proteins at regions distinct from their sorting sequences, Mol. Cell. Biol., 21, 4413, 10.1128/MCB.21.13.4413-4424.2001 Georgescu, 1999, The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region, Proc. Natl. Acad. Sci. U. S. A., 96, 10182, 10.1073/pnas.96.18.10182 Vos, 2003, RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor, J. Biol. Chem., 278, 28045, 10.1074/jbc.M300554200 Prehoda, 1999, Structure of the enabled/VASP homology 1 domain–peptide complex: a key component in the spatial control of actin assembly, Cell, 97, 471, 10.1016/S0092-8674(00)80757-6